Barclays on Monday upgraded British multinational drugmaker Hikma Pharmaceuticals (HIK.L) to equal weight from underweight and raised its price target to 17.00 pounds sterling from 13.50 pounds.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)